Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635893 · ClinicalTrials.gov registry record · Phase 4
Lower Limb Function After Spinal Cord Injury
A Phase 4 study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- Phase 4
- Development phase
- 257
- Enrollment target
NCT02635893: Completed Phase 4 study, sponsored by Shirley Ryan AbilityLab.
NCT02635893 is a Phase 4 study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 257 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02635893, a Phase 4 study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 257 participants
- Enrollment target
Study Summary
This is a randomized, experimental study that examines the physiology of central nervous system pathways contributing to the control of bilateral movements in individuals with spinal cord injuries and promotes the recovery of lower-limb motor function through the use of stimulation and locomotor training.
Interventions
- DRUG Placebo
- OTHER Training
- OTHER Stimulation
- DRUG D-Cycloserine
- OTHER Placebo Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2019-06-21 |
| Est. Completion | 2021-04-11 |
| Phase | Phase 4 |
What the finished NCT02635893 record still lists
NCT02635893 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT02635893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02635893 about?
NCT02635893 is a clinical study titled "Lower Limb Function After Spinal Cord Injury". This is a randomized, experimental study that examines the physiology of central nervous system pathways contributing to the control of bilateral movements in individuals with spinal cord injuries and promotes the recovery of lower-limb motor function through the use of stimulation and locomotor tra...
What is the current status of trial NCT02635893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 257 participants. The study started on 2019-06-21. Estimated completion is 2021-04-11.
What interventions are being tested in trial NCT02635893?
The interventions under investigation include: Placebo (DRUG), Training (OTHER), Stimulation (OTHER), D-Cycloserine (DRUG), Placebo Stimulation (OTHER).
Who is sponsoring clinical trial NCT02635893?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02635893's enrollment target sits among peer trials
257 332nd of 2000 higher than 1,669 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI